Prostate Cancer Virtual Education Summit: Overcoming the Challenges

(Sponsored Link)
This meeting will be presented live online on Tuesday, April 17, 2012, 9:00 AM– 5:00 PM
EST and then available on demand through April 17, 2013.
Last visited...2/2012.
Reviewed by...Bernard Sklar, MD.
Credit hours...9.0.
Awarded by....Northwestern University Feinberg School of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lectures.
Target Audiences...Medical oncologists, radiation oncologists, genitourinary oncologists, urologists, and oncology nurses involved in caring for patients with prostate
cancer are the primary audience for this event. Other professionals who
will find it useful include primary care physicians, family physicians, nurses and advanced practice nurses, physician assistants, and
pharmacists.
Educational material will be updated...April 17, 2012.
Financial Support...Teva.
Expiration of CME credit...April 17, 2013.
|
Prostate Cancer Virtual Education Summit: Overcoming the Challenges
will be presented live online on Tuesday, April 17, 2012, 9:00 AM– 5:00 PM
EST and then available on demand through April 17, 2013..
Topics Include:
• Prostate Cancer Screening: New Considerations
• Individualizing Therapy for the Prostate Cancer Patient
• Androgen Deprivation Therapy: Controversies and Conflicts
• Novel Therapies for Advanced Prostate Cancer
• The Hormone-Refractory Prostate Cancer Patient
• Managing Bone Health and Other Post-Intervention Issues
At the conclusion of Prostate Cancer Virtual Education Summit, you will be able to:
• Evaluate new options for prostate cancer risk testing and effectively manage practical issues associated with elevated PSA and follow-up testing.
• Initiate patient-centered discussions on individualizing prostate cancer treatments based on the patient’s age, medical history, and current health status, among others.
• Review currently available therapies for hormone-resistant or refractory prostate cancer (HRPC), identifying through a case-based method which approach is most appropriate for a specific patient.
• Discuss novel therapies available for the treatment of advanced and hormone-resistant prostate cancer, including mechanism of action, efficacy, and adverse effects.
• Properly apply the use of androgen deprivation therapy (ADT) along the spectrum of prostate cancer.
• Successfully manage bone health and other post-intervention complications, including incontinence, in patients with prostate cancer.
|